Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis
Authors:
- 1 January 2003
- journal article
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 14 (sup2) , 7-16
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Treatment of psoriasis. Part 2. Systemic therapiesJournal of the American Academy of Dermatology, 2001
- PUVA-induced phototoxicity: Incidence and causesJournal of the American Academy of Dermatology, 1997
- The safety of etretinate as long-term therapy for psoriasis: Results of the Etretinate Follow-up StudyJournal of the American Academy of Dermatology, 1995
- Long-term safety of retinoid therapyJournal of the American Academy of Dermatology, 1992
- Photochemotherapy for severe psoriasis without or in combination with acitretin: A randomized, double-blind comparison studyJournal of the American Academy of Dermatology, 1991
- Acitretin plus UVB therapy for psoriasisJournal of the American Academy of Dermatology, 1991
- A retrospective study of bone changes in adults treated with etretinateJournal of the American Academy of Dermatology, 1989
- Liver toxicity of retinoid therapyJournal of the American Academy of Dermatology, 1988
- Pulmonary complications following methotrexate therapyJournal of the American Academy of Dermatology, 1987
- Treatment of generalized pustular psoriasis with etretinate (Ro 10-9359) and methotrexateJournal of the American Academy of Dermatology, 1984